# Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/niraparib-maintenance-therapy-in-platinum-sensitive-recurrent-ovarian-cancer/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Mansoor R. Mirza,Bradley J. Monk,Jørn Herrstedt,Amit M. Oza,Sven Mahner,Andrés Redondo,Michel Fabbro,Jonathan A. Ledermann,Domenica Lorusso,Ignace Vergote,Noa Ben-Baruch,Christian Marth,Radosław Mądry,René dePont Christensen,Jonathan S. Berek,Anne Dørum,Anna V. Tinker,Andreas du Bois,Antonio González-Martı́n,Philippe Follana,Benedict B. Benigno,Per Rosenberg,Lucy Gilbert,B.J. Rimel,Joseph Buscema,John Balser,Shefali Agarwal,Ursula A. Matulonis |
| Citations | 2,477 |
| DOI | 10.1056/nejmoa1611310 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://www.nejm.org/doi/pdf/10.1056/NEJMoa1611310?articleTools=true |
| OpenAlex ID | https://openalex.org/W2528228811 |
| PMID | 27717299 |
| Type | article |
| Year | 2016 |

## Paper authors

- [Antonio González-Martı́n](https://scholariq.org/researchers/antonio-gonzalez-mart-n/)
- [Bradley J. Monk](https://scholariq.org/researchers/bradley-j-monk/)
- [Sven Mahner](https://scholariq.org/researchers/sven-mahner/)
- [Ignace Vergote](https://scholariq.org/researchers/ignace-vergote/)
- [Domenica Lorusso](https://scholariq.org/researchers/domenica-lorusso/)
- [Amit M. Oza](https://scholariq.org/researchers/amit-m-oza/)

## Paper journal

- [New England Journal of Medicine](https://scholariq.org/journals/new-england-journal-of-medicine/)

## Paper primary topic

- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)

## Paper topics

- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)
- [Ovarian cancer diagnosis and treatment](https://scholariq.org/topics/ovarian-cancer-diagnosis-and-treatment/)
- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.